what glp-1 is approved for sleep apnea Did You Know? The FDA has approved GLP-1 treatments for moderate to severe obstructive sleep apnea (OSA) in adults with obesity. This breakthrough provides a new tirzepatide for sleep apnea fda

If symptoms last more than a few weeks or become severe, it is advised to see a doctor

Ozempic (semaglutide) [prescribing information]

It also helps to keep blood sugar at a good level

Since consumption of calorie-dense palatable foods is highly pertinent to the onset and maintenance of obesity and diabetes, the potential modulation of taste sensitivity and food preference upon treatment with GLP-1-based therapies is of important clinical relevance

Gastrointestinal side effects are among the most commonly reported adverse reactions with GLP-1 receptor agonists, and acid reflux (gastro-oesophageal reflux) and heartburn feature prominently in patient experiences

Growing evidence suggests that GLP-1 RA has the potential to treat neurodegenerative diseases, particularly in diabetes-related Alzheimers disease (AD) and Parkinsons disease (PD)